Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)

Glaucoma refers to a group of optic nerve diseases associated with progressive vision loss and is one of the leading causes of irreversible blindness worldwide.1 Elevated intraocular pressure (IOP) is a key contributing factor for the progression of open-angle glaucoma (OAG) and ocular hypertension (OHT).2 IOP reduction remains a key goal for glaucoma therapy2 and reducing elevated IOP with ocular hypotensive medication has been demonstrated to delay disease progression.3-5

Source: American Journal of Ophthalmology - February 21, 2024 Category: Opthalmology Authors: Jason Bacharach, Jacob W. Brubaker, David G. Evans, Fenghe Lu, Noriko Odani-Kawabata, Takaharu Yamabe, David L. Wirta Tags: Original Articles Source Type: research